Phase II Drug Metabolism and Individualized Drug Therapy: A Focus on Functional Genetic Variation in UDP-Glucuronosyltransferases
Journal:
Current Pharmacogenomics and Personalized Medicine
Volume:
8
Page:
146-166
Author(s):
Yoshihiro Maruo, Hiroko Takahashi, Katusyuki Matsui, Hiroshi Sato and Yoshihiro Takeuchi
Editorial [Human Methylome Variation and the Rise of Epigenetic Epidemiology]
Journal:
Current Pharmacogenomics and Personalized Medicine
Volume:
8
Page:
89-91
Author(s):
James M. Flanagan
From Systems Biology to Systems Pathology: A New Subspecialty in Diagnostic and Personalized Medicine
Journal:
Current Pharmacogenomics and Personalized Medicine
Volume:
8
Page:
108-116
Author(s):
Michael J. Donovan, Jose Costa and Carlos Cordon-Cardo
Epithelial Mesenchymal Transition and Cancer Stem Cell-Like Phenotypes Facilitate Chemoresistance in Recurrent Ovarian Cancer
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
268-278
Author(s):
N. Ahmed, K. Abubaker, J. Findlay and M. Quinn
CD147/EMMPRIN and CD44 are Potential Therapeutic Targets for Metastatic Prostate Cancer
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
287-306
Author(s):
J.L. Hao, P.J. Cozzi, A. Khatri, C.A. Power and Y. Li
Inhibition of c-Met with the Specific Small Molecule Tyrosine Kinase Inhibitor SU11274 Decreases Growth and Metastasis Formation of Experimental Human Melanoma
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
332-342
Author(s):
S. Cseh, J. Tovari, J. Timar, W. Klepetko, B. Dome, G. Keri, L. Orfi, B. Szokol, G. Barna, I. Kenessey, B. Flachner, M. Mildner, J. Dobos, A. Adam, J. Berta, Z. Kramer and M. Keszthelyi
Proteomic and Metallomic Strategies for Understanding the Mode of Action of Anticancer Metallodrugs
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
10
Page:
324-337
Author(s):
Chiara Gabbiani, Francesca Magherini, Alessandra Modesti and Luigi Messori
Selenium in the Prevention and Treatment of Hepatocellular Carcinoma
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
10
Page:
338-345
Author(s):
Altaf S. Darvesh and Anupam Bishayee
Perspectives for Novel Mixed Diruthenium-Organic Drugs as Metallopharmaceuticals in Cancer Therapy
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
10
Page:
312-323
Author(s):
Denise de Oliveira Silva
A Better Platinum-Based Anticancer Drug Yet to Come?
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
10
Page:
293-301
Author(s):
Ulrike Olszewski and Gerhard Hamilton